A novel experimental immunomodulatory therapy against Nocardia brasiliensis in a BALB/c murine model.
Mycetoma has been recognized as a neglected tropical disease. There are still therapeutic challenges, especially in cases recalcitrant to standard therapy or with high risk of dissemination. Subcultures have been previously used to decrease the virulence of human pathogens. Previous reports have demonstrated that after carrying out 200 subcultures of Nocardia brasiliensis, a decrease in virulence was observed. To evaluate the effect of N. brasiliensis attenuated strains on the development of lesions in an established mycetoma infection. Female 8- to 12-week-old BALB/c mice were injected with N. brasiliensis suspension to establish a mycetoma. Sixty mice were selected and divided into 3 groups. Two groups were inoculated in the dorsum with N. brasiliensis subcultured 200 and 400 times. The other group served as control. The thickness of each lesion was measured with calipers every week for 12 weeks. After 12 weeks, we observed that inoculation of 1 x 105 CFU of N. brasiliensis attenuated strains can modify the natural history of the infection with a decrease in the size of the lesions, particularly with P400, compared to the control group (P<0.01). In this experimental evaluation of an immunomodulatory therapy with an attenuated N. brasiliensis in a murine model, there was a greater stability in the size of the lesion over time in BALB/c mice inoculated with the P400 strain. This treatment could open the possibility to use the attenuated strain as immunomodulatory therapy in cases recalcitrant to standard therapy, high risk of dissemination or in patients that developed drug adverse effects.